The Joint Undertaking "Innovative Medicines Initiative (IMI 2)" has published its 3rd Call for proposals.
Deadline: 24 March 2015 – 17:00:00 Brussels time (Stage 1)
Publication Date: 17 December 2014
Weblink (URL): http://www.imi.europa.eu/content/stage-1-14
Short Call Abstract:
Topics in the IMI 2 3rd Call for proposals are:
SSH aspects can be identified in Topic 2: “Towards a quantitative biological approach for neuropsychiatry“:
Economists should be involved to evaluate the economic impact and value of preventing the onset or delaying the progression of type 2 diabetes. They should model short- and long-term economic and public health morbidity and mortality benefit/risk assessments of a) therapeutic intervention in prediabetes to prevent or delay onset of type 2 diabetes and b) therapeutic interventions in type 2 diabetes for disease modification to reduce the rate of disease progression.
Specific participation requirements:
PLEASE REFER TO THE CALL TEXT FOR SPECIFIC PARTICIPATION REQUIREMENTS!